Burke & Herbert Bank & Trust Co. decreased its stake in Monsanto Company (NYSE:MON) by 9.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,334 shares of the basic materials company’s stock after selling 232 shares during the period. Burke & Herbert Bank & Trust Co.’s holdings in Monsanto were worth $276,000 at the end of the most recent quarter.
A number of other large investors also recently made changes to their positions in MON. First PREMIER Bank raised its stake in shares of Monsanto by 4.2% in the first quarter. First PREMIER Bank now owns 901 shares of the basic materials company’s stock valued at $102,000 after buying an additional 36 shares in the last quarter. Whitnell & Co. raised its stake in shares of Monsanto by 35.4% in the first quarter. Whitnell & Co. now owns 979 shares of the basic materials company’s stock valued at $111,000 after buying an additional 256 shares in the last quarter. Hartford Financial Management Inc. bought a new stake in shares of Monsanto during the first quarter valued at approximately $113,000. Acrospire Investment Management LLC bought a new stake in shares of Monsanto during the first quarter valued at approximately $113,000. Finally, JNBA Financial Advisors raised its stake in shares of Monsanto by 3.9% in the first quarter. JNBA Financial Advisors now owns 1,193 shares of the basic materials company’s stock valued at $135,000 after buying an additional 45 shares in the last quarter. Hedge funds and other institutional investors own 75.31% of the company’s stock.
Shares of Monsanto Company (NYSE:MON) traded down 0.15% on Tuesday, hitting $117.27. 235,300 shares of the stock were exchanged. The firm’s 50 day moving average price is $117.53 and its 200 day moving average price is $114.70. The firm has a market cap of $51.52 billion, a price-to-earnings ratio of 25.33 and a beta of 1.07. Monsanto Company has a one year low of $97.35 and a one year high of $118.97.
Monsanto (NYSE:MON) last released its quarterly earnings data on Wednesday, June 28th. The basic materials company reported $1.93 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.74 by $0.19. Monsanto had a net margin of 14.11% and a return on equity of 45.26%. The business had revenue of $4.23 billion for the quarter, compared to analysts’ expectations of $4.18 billion. During the same quarter last year, the company earned $2.17 EPS. The company’s revenue for the quarter was up 1.0% compared to the same quarter last year. Equities analysts anticipate that Monsanto Company will post $4.89 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Friday, July 28th. Investors of record on Friday, July 7th were issued a $0.54 dividend. The ex-dividend date of this dividend was Wednesday, July 5th. This represents a $2.16 dividend on an annualized basis and a dividend yield of 1.84%. Monsanto’s dividend payout ratio (DPR) is presently 46.75%.
COPYRIGHT VIOLATION WARNING: “Monsanto Company (NYSE:MON) Shares Sold by Burke & Herbert Bank & Trust Co.” was first posted by BBNS and is owned by of BBNS. If you are accessing this news story on another site, it was illegally copied and republished in violation of U.S. & international copyright & trademark legislation. The correct version of this news story can be read at https://baseballnewssource.com/markets/monsanto-company-nysemon-shares-sold-by-burke-herbert-bank-trust-co/1408417.html.
Several brokerages recently commented on MON. Citigroup Inc. reiterated a “neutral” rating and set a $125.00 price target (up from $122.00) on shares of Monsanto in a research note on Friday, April 14th. BidaskClub upgraded shares of Monsanto from a “sell” rating to a “hold” rating in a research note on Thursday, June 29th. Vetr upgraded shares of Monsanto from a “hold” rating to a “buy” rating and set a $122.35 price target on the stock in a research note on Tuesday, June 27th. Barclays PLC lifted their price target on shares of Monsanto from $115.00 to $120.00 and gave the stock an “equal weight” rating in a research note on Thursday, June 29th. Finally, Jefferies Group LLC lowered shares of Monsanto from a “buy” rating to a “hold” rating and set a $128.00 price target on the stock. in a research note on Wednesday, July 12th. Two equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and eight have given a buy rating to the company. Monsanto has a consensus rating of “Hold” and an average price target of $123.15.
In related news, EVP Steven Mizell sold 11,300 shares of the stock in a transaction dated Monday, July 3rd. The shares were sold at an average price of $118.57, for a total value of $1,339,841.00. Following the sale, the executive vice president now owns 55,011 shares of the company’s stock, valued at approximately $6,522,654.27. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP Robert T. Fraley sold 52,410 shares of the stock in a transaction dated Monday, July 10th. The stock was sold at an average price of $117.95, for a total transaction of $6,181,759.50. The disclosure for this sale can be found here. In the last ninety days, insiders sold 74,470 shares of company stock worth $8,791,281. Corporate insiders own 0.79% of the company’s stock.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with our FREE daily email newsletter.